Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
The phase 2 trial showed that the 12mg group lost 24.2% of body weight at 48 weeks versus 8.7% in the 1mg group
Here's what we'll cover Key takeaways Zepbound (tirzepatide) and Ozempic (semaglutide) are injectable GLP-1 drugs
Arch Intern Med 2000;160:2429-36
But the images are only the bait
If confirmed, treatment with semaglutide should not be restarted Gallbladder problems : Rapid weight loss can increase the risk of gallstones, which may cause right upper abdominal pain, fever, or yellowing of the skin/eyes (jaundice) Diabetic retinopathy complications : Patients with existing eye disease should be monitored closely, especially during periods of rapid improvement in blood glucose control [22] [23] Acute kidney injury : Usually associated with severe dehydration from gastrointestinal side effects Allergic reactions, though rare, can occur and may present as rash, itching, or difficulty breathing
